Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation
- PMID: 3540121
Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation
Abstract
In a young girl with a severe combined immunodeficiency, the presence of circulating maternal T lymphocytes was proven by HLA typing. Manifestations of skin graft vs host disease were associated with the persistence of maternal cells. The patient received an HLA identical bone marrow transplantation from her brother without any conditioning. The bone marrow transplantation was quickly followed by a transient and dramatic increase in skin lesions associated with fever and the finding of a high number of circulating lymphocytes and eosinophils. Lymphocytes were shown to be of donor origin and exerted a spontaneous cytotoxic activity toward maternal cells. This activity progressively disappeared within 90 days, whereas maternal cells were no longer detected in patient's blood, and skin graft vs host disease was resolved within 8 wk. Cytotoxic activity was proven to be mediated by donor T lymphocytes specific for the mother's HLA antigens. The cytotoxic activity was demonstrated to be specific for the HLA class I molecules of the mother not shared with her daughter (HLA A1, B17) as shown by the use of a series of HLA typed cells as targets. In addition, cold K562 target cells did not block the cytotoxic activity, and the kinetics of the cytotoxic activity did not correlate with that of natural killer activity emergence after the bone marrow transplantation. Patient's serum did not contain antibodies toward maternal specific HLA class I antigen. Cytotoxic activity was totally blocked by anti-T3 monoclonal antibodies and partially by anti-T8 and anti-T4. It is thus likely that donor origin cytotoxic T lymphocytes were promptly activated after bone marrow transplantation and provoked the elimination of the maternal graft after a transient exacerbation of graft vs host disease manifestations. This observation represents one of the first examples of the possible role in vivo of allogeneic cytotoxic lymphocytes in humans.
Similar articles
-
Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.Pediatrics. 1996 Sep;98(3 Pt 1):420-8. Pediatrics. 1996. PMID: 8784367
-
Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.Eur J Immunol. 1986 Feb;16(2):117-22. doi: 10.1002/eji.1830160202. Eur J Immunol. 1986. PMID: 3514234
-
The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).Exp Hematol. 1995 Dec;23(14):1667-75. Exp Hematol. 1995. PMID: 8542963
-
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.Dan Med Bull. 2002 May;49(2):89-108. Dan Med Bull. 2002. PMID: 12064093 Review.
-
Allogeneic bone marrow transplantation: relation between chimaerism and immunity.Verh K Acad Geneeskd Belg. 1998;60(2):111-43; discussion 143-5. Verh K Acad Geneeskd Belg. 1998. PMID: 9703764 Review.
Cited by
-
Skin manifestations of primary immune deficiency.Clin Rev Allergy Immunol. 2014 Apr;46(2):112-9. doi: 10.1007/s12016-013-8377-8. Clin Rev Allergy Immunol. 2014. PMID: 23760761 Review.
-
Severe combined immunodeficiencies (SCID).Clin Exp Immunol. 2000 Nov;122(2):143-9. doi: 10.1046/j.1365-2249.2000.01359.x. Clin Exp Immunol. 2000. PMID: 11091267 Free PMC article. Review. No abstract available.
-
Primary T-lymphocyte immunodeficiencies.Clin Rev Allergy Immunol. 2001 Feb;20(1):3-26. doi: 10.1385/CRIAI:20:1:3. Clin Rev Allergy Immunol. 2001. PMID: 11269227 Review. No abstract available.
-
Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.J Immunol. 2011 Feb 1;186(3):1442-9. doi: 10.4049/jimmunol.1003023. Epub 2010 Dec 22. J Immunol. 2011. PMID: 21178009 Free PMC article.
-
Omenn syndrome: a disorder of Rag1 and Rag2 genes.J Clin Immunol. 1999 Mar;19(2):87-97. doi: 10.1023/a:1020550432126. J Clin Immunol. 1999. PMID: 10226883 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials